Nevastane XS 80

Hazard statements

This product is classified as: Non-Hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. Not Hazardous – No criteria found

Precautionary statements

S24/25. Avoid contact with skin and eyes

SUSMP Classification

None allocated

ADG classification

None allocated. Not a Dangerous Good under the ADG Code

UN Number

None allocated

Potential health effects

Inhalation - Short Term Exposure: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. - Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact - Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product may be mildly irritation, but is unlikely to cause anything more than mild discomfort which should disappear once contact ceases. - Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact - Short Term Exposure: This product may be mildly irritating to eyes, but is unlikely to cause anything more than mild discomfort which should disappear once product is removed. - Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion - Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product may be mildly irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. - Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: - SWA: No significant ingredient is classified as carcinogenic by SWA. - NTP: No significant ingredient is classified as carcinogenic by NTP. - IARC: No significant ingredient is classified as carcinogenic by IARC.